Maximising return on investment through product life cycle management
14th - 15th September 2010, BSG Conference Centre, London, UK

Pharmaceutical and biopharmaceutical companies are under severe pressure to improve product pipelines, accelerate time to market, and improve margins on existing products, while maintaining strict adherence to quality principles and regulatory requirements. It is imperative that pharmaceutical and biotech companies address these business challenges to stay competitive, increase revenue, enhance profit, and reduce the risk of noncompliance.
(more…)

General economic trends worldwide will affect the over-the-counter (OTC) pharma market from 2009 onwards, with both market restraints and opportunities present. The potential of this market remains significant, despite general economic uncertainty.
(more…)

In The Emerging UMV and UGV Markets 2009-2019 it is analysed how a multitude of factors are driving increased research, development, procurement and deployment of unmanned vehicle systems. In recent years, the threat of improvised explosive devices (IEDs) in Iraq has been a major impetus for investment in robots capable of explosive ordinance disposal (EOD).

(more…)

Mobile Money Transfer is positioned to exercise considerable transformational effect on developing economies, a crucial factor for wider world economic growth. Mobile Money also enables financial services and money transfers - often initiated by urban and international immigrants - to reach poor people in rural areas. Mobile remittance services will form the first commercially viable and sustainable opportunity to reach the unbanked with low cost, no-frills financial services.
(more…)

Governmental spending on products and services for homeland security should reach $141.6bn worldwide in 2009. Visiongain expects that market to flourish from 2009 onwards, with high rewards for successful companies there.

(more…)